Myelodysplastic syndromes in South America: A multinational study of 1080 patients

There are previously reported data describing differences between Asian and European patients with Myelodysplastic Syndromes (MDS), few direct comparisons based on cancer registration characteristics or using cohorts to validate scoring systems. This is the first study from South‐America, which atte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of hematology 2015-10, Vol.90 (10), p.851-858
Hauptverfasser: Belli, Carolina B., Pinheiro, Ronald Feitosa, Bestach, Yesica, Larripa, Irene B., da Silva Tanizawa, Roberta Sandra, Alfonso, Graciela, Gonzalez, Jacqueline, Rosenhain, Mariana, Watman, Nora, Cavalcante de Andrade Silva, Marcela, Negri Aranguren, Pedro, García Rivello, Hernán, Magalhaes, Silvia M.M., Valladares, Ximena, Undurraga, María S., Velloso, Elvira R.P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 858
container_issue 10
container_start_page 851
container_title American journal of hematology
container_volume 90
creator Belli, Carolina B.
Pinheiro, Ronald Feitosa
Bestach, Yesica
Larripa, Irene B.
da Silva Tanizawa, Roberta Sandra
Alfonso, Graciela
Gonzalez, Jacqueline
Rosenhain, Mariana
Watman, Nora
Cavalcante de Andrade Silva, Marcela
Negri Aranguren, Pedro
García Rivello, Hernán
Magalhaes, Silvia M.M.
Valladares, Ximena
Undurraga, María S.
Velloso, Elvira R.P.
description There are previously reported data describing differences between Asian and European patients with Myelodysplastic Syndromes (MDS), few direct comparisons based on cancer registration characteristics or using cohorts to validate scoring systems. This is the first study from South‐America, which attempts to describe demographic, clinical features, and outcome of MDS patients. We retrospectively analyzed 1,080 patients with de novo MDS from Argentina (635), Brazil (345), and Chile (100). Chilean patients were younger (P = 0.001) with female preponderance (P = 0.071). Brazilian series showed a higher predominance of RARS subtype regarding FAB and WHO classifications (P 
doi_str_mv 10.1002/ajh.24097
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1715659774</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1715659774</sourcerecordid><originalsourceid>FETCH-LOGICAL-p3847-c0d5e7684cd86ca7b1a7833dddf94b583f8068432ef62cc7c65044305c25cf5b3</originalsourceid><addsrcrecordid>eNpdkUtLw0AUhQdRbK0u_AMy4MZN2juZZ9yVolapCD7WYTIzoSl5mUmQ_HtjWl24uod7Pi7ccxC6JDAnAOFC77bzkEEkj9CUQCQCJXh4jKZABRk0RBN05v0OgBCm4BRNQkGAcUmn6PW5d3lle1_n2reZwb4vbVMVzuOsxG9V127xsnBNZvQtXuKiy9us1G1WlTrHvu1sj6sUE1CA62Htytafo5NU595dHOYMfdzfva_Wwebl4XG13AQ1VUwGBix3UihmrBJGy4RoqSi11qYRS7iiqYLBpaFLRWiMNIIDYxS4CblJeUJn6GZ_t26qz875Ni4yb1ye69JVnY-JJFzwSEo2oNf_0F3VNcMLI0UjQvlIXR2oLimcjesmK3TTx79pDcBiD3xluev_fALxTw3xUEM81hAvn9ajoN88o3gu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1713913574</pqid></control><display><type>article</type><title>Myelodysplastic syndromes in South America: A multinational study of 1080 patients</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><source>Wiley Online Library Free Content</source><source>EZB Electronic Journals Library</source><creator>Belli, Carolina B. ; Pinheiro, Ronald Feitosa ; Bestach, Yesica ; Larripa, Irene B. ; da Silva Tanizawa, Roberta Sandra ; Alfonso, Graciela ; Gonzalez, Jacqueline ; Rosenhain, Mariana ; Watman, Nora ; Cavalcante de Andrade Silva, Marcela ; Negri Aranguren, Pedro ; García Rivello, Hernán ; Magalhaes, Silvia M.M. ; Valladares, Ximena ; Undurraga, María S. ; Velloso, Elvira R.P.</creator><creatorcontrib>Belli, Carolina B. ; Pinheiro, Ronald Feitosa ; Bestach, Yesica ; Larripa, Irene B. ; da Silva Tanizawa, Roberta Sandra ; Alfonso, Graciela ; Gonzalez, Jacqueline ; Rosenhain, Mariana ; Watman, Nora ; Cavalcante de Andrade Silva, Marcela ; Negri Aranguren, Pedro ; García Rivello, Hernán ; Magalhaes, Silvia M.M. ; Valladares, Ximena ; Undurraga, María S. ; Velloso, Elvira R.P.</creatorcontrib><description>There are previously reported data describing differences between Asian and European patients with Myelodysplastic Syndromes (MDS), few direct comparisons based on cancer registration characteristics or using cohorts to validate scoring systems. This is the first study from South‐America, which attempts to describe demographic, clinical features, and outcome of MDS patients. We retrospectively analyzed 1,080 patients with de novo MDS from Argentina (635), Brazil (345), and Chile (100). Chilean patients were younger (P = 0.001) with female preponderance (P = 0.071). Brazilian series showed a higher predominance of RARS subtype regarding FAB and WHO classifications (P &lt; 0.001). Hemoglobin levels were significantly lower in Brazilian and Chilean series (P &lt; 0.001), and Chilean series also showed a lower platelet count (P = 0.028), with no differences concerning the neutrophil count, % BM blast, and the distribution of cytogenetic risk groups (P &gt; 0.05). Chilean series depicted a lower overall survival (OS; 35 months vs. 56 months‐Argentine; 55 months‐Brazil, P = 0.030), which was consistent with a higher predominance of the high‐risk group according both to the IPSS and IPSS‐R (P = 0.046 and P &lt; 0.001). The IPSS‐R system and its variables showed a good reproducibility to predict clinical outcome for the whole South‐American population. Epidemiological and clinical characteristics, distribution among prognostic subgroups, the OS, and the access to disease modifying therapies were more similar between Argentinean and Brazilian compared with Chilean MDS series. This will need further analysis in a larger group of patients. Descriptive and comparative studies are necessary to establish epidemiological features useful for public health attitudes to generate suitable therapeutic schemes. Am. J. Hematol. 90:851–858, 2015. © 2015 Wiley Periodicals, Inc.</description><identifier>ISSN: 0361-8609</identifier><identifier>EISSN: 1096-8652</identifier><identifier>DOI: 10.1002/ajh.24097</identifier><identifier>PMID: 26104573</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Age Factors ; Aged ; Aged, 80 and over ; Female ; Hematology ; Humans ; Male ; Middle Aged ; Myelodysplastic Syndromes - mortality ; Myelodysplastic Syndromes - therapy ; Retrospective Studies ; South America - epidemiology</subject><ispartof>American journal of hematology, 2015-10, Vol.90 (10), p.851-858</ispartof><rights>2015 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajh.24097$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajh.24097$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,1427,27901,27902,45550,45551,46384,46808</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26104573$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Belli, Carolina B.</creatorcontrib><creatorcontrib>Pinheiro, Ronald Feitosa</creatorcontrib><creatorcontrib>Bestach, Yesica</creatorcontrib><creatorcontrib>Larripa, Irene B.</creatorcontrib><creatorcontrib>da Silva Tanizawa, Roberta Sandra</creatorcontrib><creatorcontrib>Alfonso, Graciela</creatorcontrib><creatorcontrib>Gonzalez, Jacqueline</creatorcontrib><creatorcontrib>Rosenhain, Mariana</creatorcontrib><creatorcontrib>Watman, Nora</creatorcontrib><creatorcontrib>Cavalcante de Andrade Silva, Marcela</creatorcontrib><creatorcontrib>Negri Aranguren, Pedro</creatorcontrib><creatorcontrib>García Rivello, Hernán</creatorcontrib><creatorcontrib>Magalhaes, Silvia M.M.</creatorcontrib><creatorcontrib>Valladares, Ximena</creatorcontrib><creatorcontrib>Undurraga, María S.</creatorcontrib><creatorcontrib>Velloso, Elvira R.P.</creatorcontrib><title>Myelodysplastic syndromes in South America: A multinational study of 1080 patients</title><title>American journal of hematology</title><addtitle>Am J Hematol</addtitle><description>There are previously reported data describing differences between Asian and European patients with Myelodysplastic Syndromes (MDS), few direct comparisons based on cancer registration characteristics or using cohorts to validate scoring systems. This is the first study from South‐America, which attempts to describe demographic, clinical features, and outcome of MDS patients. We retrospectively analyzed 1,080 patients with de novo MDS from Argentina (635), Brazil (345), and Chile (100). Chilean patients were younger (P = 0.001) with female preponderance (P = 0.071). Brazilian series showed a higher predominance of RARS subtype regarding FAB and WHO classifications (P &lt; 0.001). Hemoglobin levels were significantly lower in Brazilian and Chilean series (P &lt; 0.001), and Chilean series also showed a lower platelet count (P = 0.028), with no differences concerning the neutrophil count, % BM blast, and the distribution of cytogenetic risk groups (P &gt; 0.05). Chilean series depicted a lower overall survival (OS; 35 months vs. 56 months‐Argentine; 55 months‐Brazil, P = 0.030), which was consistent with a higher predominance of the high‐risk group according both to the IPSS and IPSS‐R (P = 0.046 and P &lt; 0.001). The IPSS‐R system and its variables showed a good reproducibility to predict clinical outcome for the whole South‐American population. Epidemiological and clinical characteristics, distribution among prognostic subgroups, the OS, and the access to disease modifying therapies were more similar between Argentinean and Brazilian compared with Chilean MDS series. This will need further analysis in a larger group of patients. Descriptive and comparative studies are necessary to establish epidemiological features useful for public health attitudes to generate suitable therapeutic schemes. Am. J. Hematol. 90:851–858, 2015. © 2015 Wiley Periodicals, Inc.</description><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Female</subject><subject>Hematology</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myelodysplastic Syndromes - mortality</subject><subject>Myelodysplastic Syndromes - therapy</subject><subject>Retrospective Studies</subject><subject>South America - epidemiology</subject><issn>0361-8609</issn><issn>1096-8652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkUtLw0AUhQdRbK0u_AMy4MZN2juZZ9yVolapCD7WYTIzoSl5mUmQ_HtjWl24uod7Pi7ccxC6JDAnAOFC77bzkEEkj9CUQCQCJXh4jKZABRk0RBN05v0OgBCm4BRNQkGAcUmn6PW5d3lle1_n2reZwb4vbVMVzuOsxG9V127xsnBNZvQtXuKiy9us1G1WlTrHvu1sj6sUE1CA62Htytafo5NU595dHOYMfdzfva_Wwebl4XG13AQ1VUwGBix3UihmrBJGy4RoqSi11qYRS7iiqYLBpaFLRWiMNIIDYxS4CblJeUJn6GZ_t26qz875Ni4yb1ye69JVnY-JJFzwSEo2oNf_0F3VNcMLI0UjQvlIXR2oLimcjesmK3TTx79pDcBiD3xluev_fALxTw3xUEM81hAvn9ajoN88o3gu</recordid><startdate>201510</startdate><enddate>201510</enddate><creator>Belli, Carolina B.</creator><creator>Pinheiro, Ronald Feitosa</creator><creator>Bestach, Yesica</creator><creator>Larripa, Irene B.</creator><creator>da Silva Tanizawa, Roberta Sandra</creator><creator>Alfonso, Graciela</creator><creator>Gonzalez, Jacqueline</creator><creator>Rosenhain, Mariana</creator><creator>Watman, Nora</creator><creator>Cavalcante de Andrade Silva, Marcela</creator><creator>Negri Aranguren, Pedro</creator><creator>García Rivello, Hernán</creator><creator>Magalhaes, Silvia M.M.</creator><creator>Valladares, Ximena</creator><creator>Undurraga, María S.</creator><creator>Velloso, Elvira R.P.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>201510</creationdate><title>Myelodysplastic syndromes in South America: A multinational study of 1080 patients</title><author>Belli, Carolina B. ; Pinheiro, Ronald Feitosa ; Bestach, Yesica ; Larripa, Irene B. ; da Silva Tanizawa, Roberta Sandra ; Alfonso, Graciela ; Gonzalez, Jacqueline ; Rosenhain, Mariana ; Watman, Nora ; Cavalcante de Andrade Silva, Marcela ; Negri Aranguren, Pedro ; García Rivello, Hernán ; Magalhaes, Silvia M.M. ; Valladares, Ximena ; Undurraga, María S. ; Velloso, Elvira R.P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p3847-c0d5e7684cd86ca7b1a7833dddf94b583f8068432ef62cc7c65044305c25cf5b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Female</topic><topic>Hematology</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myelodysplastic Syndromes - mortality</topic><topic>Myelodysplastic Syndromes - therapy</topic><topic>Retrospective Studies</topic><topic>South America - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Belli, Carolina B.</creatorcontrib><creatorcontrib>Pinheiro, Ronald Feitosa</creatorcontrib><creatorcontrib>Bestach, Yesica</creatorcontrib><creatorcontrib>Larripa, Irene B.</creatorcontrib><creatorcontrib>da Silva Tanizawa, Roberta Sandra</creatorcontrib><creatorcontrib>Alfonso, Graciela</creatorcontrib><creatorcontrib>Gonzalez, Jacqueline</creatorcontrib><creatorcontrib>Rosenhain, Mariana</creatorcontrib><creatorcontrib>Watman, Nora</creatorcontrib><creatorcontrib>Cavalcante de Andrade Silva, Marcela</creatorcontrib><creatorcontrib>Negri Aranguren, Pedro</creatorcontrib><creatorcontrib>García Rivello, Hernán</creatorcontrib><creatorcontrib>Magalhaes, Silvia M.M.</creatorcontrib><creatorcontrib>Valladares, Ximena</creatorcontrib><creatorcontrib>Undurraga, María S.</creatorcontrib><creatorcontrib>Velloso, Elvira R.P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Belli, Carolina B.</au><au>Pinheiro, Ronald Feitosa</au><au>Bestach, Yesica</au><au>Larripa, Irene B.</au><au>da Silva Tanizawa, Roberta Sandra</au><au>Alfonso, Graciela</au><au>Gonzalez, Jacqueline</au><au>Rosenhain, Mariana</au><au>Watman, Nora</au><au>Cavalcante de Andrade Silva, Marcela</au><au>Negri Aranguren, Pedro</au><au>García Rivello, Hernán</au><au>Magalhaes, Silvia M.M.</au><au>Valladares, Ximena</au><au>Undurraga, María S.</au><au>Velloso, Elvira R.P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myelodysplastic syndromes in South America: A multinational study of 1080 patients</atitle><jtitle>American journal of hematology</jtitle><addtitle>Am J Hematol</addtitle><date>2015-10</date><risdate>2015</risdate><volume>90</volume><issue>10</issue><spage>851</spage><epage>858</epage><pages>851-858</pages><issn>0361-8609</issn><eissn>1096-8652</eissn><abstract>There are previously reported data describing differences between Asian and European patients with Myelodysplastic Syndromes (MDS), few direct comparisons based on cancer registration characteristics or using cohorts to validate scoring systems. This is the first study from South‐America, which attempts to describe demographic, clinical features, and outcome of MDS patients. We retrospectively analyzed 1,080 patients with de novo MDS from Argentina (635), Brazil (345), and Chile (100). Chilean patients were younger (P = 0.001) with female preponderance (P = 0.071). Brazilian series showed a higher predominance of RARS subtype regarding FAB and WHO classifications (P &lt; 0.001). Hemoglobin levels were significantly lower in Brazilian and Chilean series (P &lt; 0.001), and Chilean series also showed a lower platelet count (P = 0.028), with no differences concerning the neutrophil count, % BM blast, and the distribution of cytogenetic risk groups (P &gt; 0.05). Chilean series depicted a lower overall survival (OS; 35 months vs. 56 months‐Argentine; 55 months‐Brazil, P = 0.030), which was consistent with a higher predominance of the high‐risk group according both to the IPSS and IPSS‐R (P = 0.046 and P &lt; 0.001). The IPSS‐R system and its variables showed a good reproducibility to predict clinical outcome for the whole South‐American population. Epidemiological and clinical characteristics, distribution among prognostic subgroups, the OS, and the access to disease modifying therapies were more similar between Argentinean and Brazilian compared with Chilean MDS series. This will need further analysis in a larger group of patients. Descriptive and comparative studies are necessary to establish epidemiological features useful for public health attitudes to generate suitable therapeutic schemes. Am. J. Hematol. 90:851–858, 2015. © 2015 Wiley Periodicals, Inc.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>26104573</pmid><doi>10.1002/ajh.24097</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0361-8609
ispartof American journal of hematology, 2015-10, Vol.90 (10), p.851-858
issn 0361-8609
1096-8652
language eng
recordid cdi_proquest_miscellaneous_1715659774
source Wiley-Blackwell Journals; MEDLINE; Wiley Online Library Free Content; EZB Electronic Journals Library
subjects Age Factors
Aged
Aged, 80 and over
Female
Hematology
Humans
Male
Middle Aged
Myelodysplastic Syndromes - mortality
Myelodysplastic Syndromes - therapy
Retrospective Studies
South America - epidemiology
title Myelodysplastic syndromes in South America: A multinational study of 1080 patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T16%3A50%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myelodysplastic%20syndromes%20in%20South%20America:%20A%20multinational%20study%20of%201080%20patients&rft.jtitle=American%20journal%20of%20hematology&rft.au=Belli,%20Carolina%20B.&rft.date=2015-10&rft.volume=90&rft.issue=10&rft.spage=851&rft.epage=858&rft.pages=851-858&rft.issn=0361-8609&rft.eissn=1096-8652&rft_id=info:doi/10.1002/ajh.24097&rft_dat=%3Cproquest_pubme%3E1715659774%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1713913574&rft_id=info:pmid/26104573&rfr_iscdi=true